Assess whether regulatory approval is a timing risk or a deal risk (0a2323)

SITUATION In a PE platform evaluating a founder-led SaaS add-on, IT diligence showing two ERPs and no chart of accounts map put management-team retention and key-person map in play. Integration-risk PMO should decide whether regulatory approval is a timing risk or a deal risk without filling gaps management-team retention and key-person map does not contain.

DECISION Integration-risk PMO in a PE platform evaluating a founder-led SaaS add-on must choose Regulatory approval is a timing risk / A deal risk using management-team retention and key-person map after IT diligence showing two ERPs and no chart of accounts map.

HYPOTHESES TO TEST 1. The population in management-team retention and key-person map is the one IT diligence showing two ERPs and no chart of accounts map named, so Regulatory approval is a timing risk follows for this People and Contracts file. 2. The population in management-team retention and key-person map is adjacent only to IT diligence showing two ERPs and no chart of accounts map; A deal risk is the honest M&A Due Diligence call. 3. A PE platform evaluating a founder-led SaaS add-on already contained IT diligence showing two ERPs and no chart of accounts map before management-team retention and key-person map arrived; no new People and Contracts path. 4. Provenance on management-team retention and key-person map after IT diligence showing two ERPs and no chart of accounts map is broken; do not pick Regulatory approval is a timing risk or A deal risk yet.

ANALYSIS REQUIRED 1. Tie quality-of-earnings, working-capital, and contingent items in management-team retention and key-person map to regulatory approval is a. 2. Name the document integration-risk PMO still needs before signing. 3. Test whether IT diligence showing two ERPs and no chart of accounts map is a diligence gap, a price chip, or a walk-away. 4. For this M&A Due Diligence People and Contracts file, read management-team retention and key-person map against IT diligence showing two ERPs and no chart of accounts map and write the one fact that would move regulatory approval is a for integration-risk PMO.

RECOMMENDATION Choose Regulatory approval is a timing risk / A deal risk on this M&A Due Diligence / People and Contracts packet (management-team retention and key-person map after IT diligence showing two ERPs and no chart of accounts map). Lead with the M&A Due Diligence option management-team retention and key-person map can support after IT diligence showing two ERPs and no chart of accounts map, then the two facts that force it, then the Monday action for integration-risk PMO in a PE platform evaluating a founder-led SaaS add-on.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on regulatory approval is a, then the evidence in management-team retention and key-person map, then the action for integration-risk PMO - Hypothesis scorecard against management-team retention and key-person map: supported / rejected / untestable - Named option among Regulatory approval is a timing risk, A deal risk and the fact that kills the others - Owner and next date for integration-risk PMO in a PE platform evaluating a founder-led SaaS add-on